Bankole Johnson - Feb 23, 2022 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Chief Medical Officer
Signature
/s/ Bankole A. Johnson
Stock symbol
ADIL
Transactions as of
Feb 23, 2022
Transactions value $
$0
Form type
4
Date filed
2/25/2022, 02:18 PM
Previous filing
Oct 6, 2021
Next filing
Jun 2, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADIL Employee Stock Option Award $0 +35K $0.00 35K Feb 23, 2022 Common Stock 35K $2.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022.